Clinical Trial Update: Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia

View source ↗

Summary

This clinical trial update reports on short-term treatment satisfaction for hidradenitis suppurativa patients initiated on secukinumab (Cosentyx) in routine cli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hidradenitis Suppurativa (HS) | Status: RECRUITING